Healthcare Industry News: RT Technology
News Release - August 16, 2010
RMD Instruments and Cunningham Woodland Announce Distribution Agreement for Navigator System and Surgical ProbesWATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--RMD Instruments Corp, a wholly owned subsidiary of Dynasil Corporation of America (OTCBB:DYSL ) today announced that they and Cunningham Woodland, Inc. a leading specialty surgical supply company, have entered into an agreement whereby Cunningham will handle exclusive New England distribution of RMD’s Navigator™ system and gamma surgical probes for advanced cancer detection and evaluation, which help doctors more accurately locate cancer cells for targeted therapy.
Mark Caldwell, General Manager of RMD, commented “We are excited that Cunningham Woodland is distributing our Navigator™ GPS line of products which provides gamma localization of tissue during surgery. The system and mapping probes are intended for use in localizing suspected cancer lesions not visible with other imaging modalities, providing early detection and evaluation of disease extent. We think the combination of their reputation and marketing horsepower, together with our Navigator GPS product line, will be a winning combination in this critical segment of the cancer surgery market.”
“Cunningham has been serving the New England market for over 25 years and is a respected distributor in this important region,” added Jim Lovejoy, General Sales Manager, of RMD’s medical products. “Their present product portfolio and positive reputation in the surgical community, including relationships with the operating room personnel, heads of specialties, and key surgeons, is a good match for the Navigator™ product line.”
“We are thrilled to be representing a local manufacturer with state of the aRT Technology, extensive research and development and a product line that benefits both the patient and the surgeon,” stated George Woodland, President of Cunningham Woodland, Inc.
About RMD Instruments Corp.
RMD Instruments Corp (RMD), a wholly owned subsidiary of Dynasil Corporation of America, is a diversified technology company providing innovative products to a wide range of markets and disciplines. The company has a rich history of applying science and research to develop products that improve healthcare, enhance security and deliver advanced solutions to businesses around the world. RMD has been producing the Navigator™ GPS Lymphatic Mapping System since 1999. RMD is based in Watertown, Massachusetts.
Dynasil Corporation of America (OTCBB: DYSL ), is a provider of technology, products, services and solutions aimed at making the world safer and healthier. The company supplies a broad range of customers by serving their specific needs in the medical, industrial, and homeland security/defense markets. The Company has operations in New Jersey, New York, Massachusetts and the UK.
This news release may contain forward-looking statements usually containing the words "believe," "expect," “plan”, “target”, “intend” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Future results of operations, projections, and expectations, which may relate to this release, involve certain risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the factors detailed in the Company's Annual Report or Form 10-K and in the Company's other Securities and Exchange Commission filings, continuation of existing market conditions and demand for our products. Dynasil undertakes no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors that may affect such forward-looking statements.
Source: RMD Instruments
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.